Morning Brew Daily cover image

Tylenol Maker Bought for $40B & Coke Doubles Down on AI Ads

Morning Brew Daily

00:00

Kimberly-Clark's $49B Bet on Kenvue

Neil outlines the acquisition of Kenvue by Kimberly-Clark and the market reaction to Tylenol-related legal risks.

Play episode from 03:08
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app